Perturbation of dendritic protrusions in intellectual disability

Progress in Brain Research

Volumn 197, Issue , 2012, Pages 153-168

  Levenga, Josien ^a   Willemsen, Rob ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Down syndrome; Fragile X syndrome; Mental retardation; Rett syndrome; Spines

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; AMPA RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; FRAGILE X MENTAL RETARDATION PROTEIN; GIRK2 PROTEIN; METHYL CPG BINDING PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 5; P21 ACTIVATED KINASE; PHOSPHATASE; PROTEIN; SAPAP1 PROTEIN; SAPAP3 PROTEIN; STRIATAL ENRICHED PHOSPHATASE; TAU PROTEIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; DNA METHYLATION; DOWN SYNDROME; DYRK1A GENE; EMBRYONIC STEM CELL; FRAGILE X SYNDROME; GENE; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; KCNJ6 GENE; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; RETT SYNDROME; SPINE DISEASE; SYNAPTOSOME; TRISOMY 21;

EID: 84860316461     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-54299-1.00008-X     Document Type: Chapter

References (103)

1. Abu-Elneel K., Ochiishi T., Medina M., Remedi M., Gastaldi L., Caceres A., et al. A delta-catenin signaling pathway leading to dendritic protrusions. Journal of Biological Chemistry 2008, 283:32781-32791.
2. Ahn K.J., Jeong H.K., Choi H.S., Ryoo S.R., Kim Y.J., Goo J.S., et al. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiology of Disease 2006, 22:463-472.
3. Altafaj X., Dierssen M., Baamonde C., Marti E., Visa J., Guimera J., et al. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Human Molecular Genetics 2001, 10:1915-1923.
4. Amano K., Sago H., Uchikawa C., Suzuki T., Kotliarova S.E., Nukina N., et al. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Human Molecular Genetics 2004, 13:1333-1340.
5. Antar L.N., Li C., Zhang H., Carroll R.C., Bassell G.J. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Molecular and Cellular Neuroscience 2006, 32:37-48.
6. Armstrong D.D. Neuropathology of Rett syndrome. Mental Retardation and Developmental Disabilities Research Reviews 2002, 8:72-76.
7. Bakker C.E., Verheij C., Willemsen R., Vanderhelm R., Oerlemans F., Vermey M., et al. Fmr1 knockout mice: A model to study fragile X mental retardation. Cell 1994, 78:23-33.
8. Bapat S., Galande S. Association by guilt: Identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome. Bioessays 2005, 27:676-680.
9. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends in Neurosciences 2004, 27:370-377.
10. Belichenko P.V., Oldfors A., Hagberg B., Dahlstrom A. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994, 5:1509-1513.
11. Belichenko P.V., Kleschevnikov A.M., Salehi A., Epstein C.J., Mobley W.C. Synaptic and cognitive abnormalities in mouse models of Down syndrome: Exploring genotype-phenotype relationships. The Journal of Comparative Neurology 2007, 504:329-345.
12. Belichenko N.P., Belichenko P.V., Kleschevnikov A.M., Salehi A., Reeves R.H., Mobley W.C. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. Journal of Neuroscience 2009, 29:5938-5948.
13. Belichenko N.P., Belichenko P.V., Mobley W.C. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiology of Disease 2009, 34:71-77.
14. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., et al. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: Evidence for disruption of neuronal networks. The Journal of Comparative Neurology 2009, 514:240-258.
15. Benavides-Piccione R., Dierssen M., Ballesteros-Yanez I., Martinez de Lagran M., Arbones M.L., Fotaki V., et al. Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse. Neurobiology of Disease 2005, 20:115-122.
16. Bilousova T., Dansie L., Ngo M., Aye J., Charles J.R., Ethell D.W., et al. Minocycline promotes dendritic spine maturation and improves behavioral performance in the fragile X mouse model. Journal of Medical Genetics 2008, 46:94-102.
17. Boda B., Dubos A., Muller D. Signaling mechanisms regulating synapse formation and function in mental retardation. Current Opinion in Neurobiology 2010, 20:519-527.
18. Branchi I., Bichler Z., Minghetti L., Delabar J.M., Malchiodi-Albedi F., Gonzalez M.C., et al. Transgenic mouse in vivo library of human Down syndrome critical region 1: Association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. Journal of Neuropathology and Experimental Neurology 2004, 63:429-440.
19. Castets M., Schaeffer C., Bechara E., Schenck A., Khandjian E.W., Luche S., et al. FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts. Human Molecular Genetics 2005, 14:835-844.
20. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: From clinic to neurobiology. Neuron 2007, 56:422-437.
21. Chao H.T., Zoghbi H.Y., Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56:58-65.
22. Chapleau C.A., Calfa G.D., Lane M.C., Albertson A.J., Larimore J.L., Kudo S., et al. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiology of Disease 2009, 35:219-233.
23. Chelly J., Khelfaoui M., Francis F., Cherif B., Bienvenu T. Genetics and pathophysiology of mental retardation. European Journal of Human Genetics 2006, 14:701-713.
24. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genetics 2001, 27:327-331.
25. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
26. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., et al. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:5401-5404.
27. Costa A.C., Grybko M.J. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome. Neuroscience Letters 2005, 382:317-322.
28. Cramer N.P., Best T.K., Stoffel M., Siarey R.J., Galdzicki Z. GABAB-GIRK2-mediated signaling in Down syndrome. Advances in Pharmacology 2010, 58:397-426.
29. Cruz-Martin A., Crespo M., Portera-Cailliau C. Delayed stabilization of dendritic spines in fragile X mice. Journal of Neuroscience 2010, 30:7793-7803.
30. Dani V.S., Chang Q., Maffei A., Turrigiano G.G., Jaenisch R., Nelson S.B. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12560-12565.
31. De Vrij F.M.S., Levenga J., Van der Linde H.C., Koekkoek S.K., De Zeeuw C.I., Nelson D.L., et al. Rescue of behavioral phenotype and neuronal protrusion morphology in FMR1 KO mice. Neurobiology of Disease 2008, 31:127-132.
32. Dierssen M., Benavides-Piccione R., Martinez-Cue C., Estivill X., Florez J., Elston G.N., et al. Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: Effects of environmental enrichment. Cerebral Cortex 2003, 13:758-764.
33. Dierssen M., Herault Y., Estivill X. Aneuploidy: From a physiological mechanism of variance to Down syndrome. Physiological Reviews 2009, 89:887-920.
34. Fukuda T., Yamashita Y., Nagamitsu S., Miyamoto K., Jin J.J., Ohmori I., et al. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms. Brain Development 2005, 27:211-217.
35. Galvez R., Greenough W.T. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. American Journal of Medical Genetics. Part A 2005, 135:155-160.
36. Grant S.G., Marshall M.C., Page K.L., Cumiskey M.A., Armstrong J.D. Synapse proteomics of multiprotein complexes: En route from genes to nervous system diseases. Human Molecular Genetics 2005, 14:R225-R234.
37. Grossman A.W., Aldridge G.M., Weiler I.J., Greenough W.T. Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. Journal of Neuroscience 2006, 26:7151-7155.
38. Grossman A.W., Elisseou N.M., McKinney B.C., Greenough W.T. Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Research 2006, 1084:158-164.
39. Grossman A.W., Aldridge G.M., Lee K.J., Zeman M.K., Jun C.S., Azam H.S., et al. Developmental characteristics of dendritic spines in the dentate gyrus of Fmr1 knockout mice. Brain Research 2010, 1355:221-227.
40. Gundersen G.G., Gomes E.R., Wen Y. Cortical control of microtubule stability and polarization. Current Opinion in Cell Biology 2004, 16:106-112.
41. Gusev P.A., Cui C., Alkon D.L., Gubin A.N. Topography of Arc/Arg3.1 mRNA expression in the dorsal and ventral hippocampus induced by recent and remote spatial memory recall: Dissociation of CA3 and CA1 activation. Journal of Neuroscience 2005, 25:9384-9397.
42. Guy J., Cheval H., Selfridge J., Bird A. The role of MeCP2 in the brain. Annual Review of Cell and Developmental Biology 2011, 10:631-652.
43. Guzowski J.F., Miyashita T., Chawla M.K., Sanderson J., Maes L.I., Houston F.P., et al. Recent behavioral history modifies coupling between cell activity and Arc gene transcription in hippocampal CA1 neurons. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:1077-1082.
44. Hagerman R.J. The physical and behavioural phenotype. Fragile-X syndrome: Diagnosis, treatment and research 2002, 3-109. The Johns Hopkins University Press, Baltimore. R.J. Hagerman, P. Hagerman (Eds.).
45. Hayashi M.L., Rao B.S., Seo J.S., Choi H.S., Dolan B.M., Choi S.Y., et al. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:11489-11494.
46. Hinton V.J., Brown W.T., Wisniewski K., Rudelli R.D. Analysis of neocortex in three males with the fragile X syndrome. American Journal of Medical Genetics 1991, 41:289-294.
47. Hu H., Qin Y., Bochorishvili G., Zhu Y., van Aelst L., Zhu J.J. Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome. Journal of Neuroscience 2008, 28:7847-7862.
48. Huber K.M., Roder J.C., Bear M.F. Chemical induction of mGluR5- and protein synthesis-dependent long- term depression in hippocampal area CA1. Journal of Neurophysiology 2001, 86:321-325.
49. Irwin S.A., Galvez R., Greenough W.T. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cerebral Cortex 2000, 10:1038-1044.
50. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. American Journal of Medical Genetics 2001, 98:161-167.
51. Irwin S.A., Idupulapati M., Gilbert M.E., Harris J.B., Chakravarti A.B., Rogers E.J., et al. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. American Journal of Medical Genetics 2002, 111:140-146.
52. Kandel E.R. The molecular biology of memory storage: A dialogue between genes and synapses. Science 2001, 294:1030-1038.
53. Kasai H., Fukuda M., Watanabe S., Hayashi-Takagi A., Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends in Neurosciences 2010, 33:121-129.
54. Kiebler M.A., Bassell G.J. Neuronal RNA granules: Movers and makers. Neuron 2006, 51:685-690.
55. Kishi N., Macklis J.D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Molecular and Cellular Neuroscience 2004, 27:306-321.
56. Kuhn D.E., Nuovo G.J., Terry A.V., Martin M.M., Malana G.E., Sansom S.E., et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. Journal of Biological Chemistry 2010, 285:1529-1543.
57. Kurt M.A., Davies D.C., Kidd M., Dierssen M., Flórez J. Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Research 2000, 858:191-197.
58. Kurt M.A., Kafa M.I., Dierssen M., Davies D.C. Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome. Brain Research 2004, 1022:101-109.
59. Levenga J., de Vrij F.M., Oostra B.A., Willemsen R. Potential therapeutic interventions for fragile X syndrome. Trends in Molecular Medicine 2010, 16:516-527.
60. Levenga J., de Vrij F.M., Buijsen R.A., Li T., Nieuwenhuizen I.M., Pop A., et al. Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice. Neurobiology of Learning and Memory 2011, 95:467-472.
61. Levenga J., Hayashi S., de Vrij F.M., Koekkoek S.K., van der Linde H.C., Nieuwenhuizen I., et al. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome. Neurobiology of Disease 2011, 42:311-317.
62. Li Z., Yu T., Morishima M., Pao A., LaDuca J., Conroy J., et al. Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Human Molecular Genetics 2007, 16:1359-1366.
63. Lu R., Wang H., Liang Z., Ku L., O'Donnell W.T., Li W., et al. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15201-15206.
64. Malenka R.C., Bear M.F. LTP and LTD: An embarrassment of riches. Neuron 2004, 44:5-21.
65. Matsuzaki M., Honkura N., Ellis-Davies G.C., Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature 2004, 429:761-766.
66. McKinney B.C., Grossman A.W., Elisseou N.M., Greenough W.T. Dendritic spine abnormalities in the occipital cortex of C57BL/6 Fmr1 knockout mice. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2005, 136B:98-102.
67. Newey S.E., Velamoor V., Govek E.E., Van Aelst L. Rho GTPases, dendritic structure, and mental retardation. Journal of Neurobiology 2005, 64:58-74.
68. Nimchinsky E.A., Oberlander A.M., Svoboda K. Abnormal development of dendritic spines in fmr1 knock-out mice. Journal of Neuroscience 2001, 21:5139-5146.
69. O'Doherty A., Ruf S., Mulligan C., Hildreth V., Errington M.L., Cooke S., et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 2005, 309:2033-2037.
70. Oostra B., Nelson D.L. Animal models of fragile X syndrome: Mice and flies. Genetic instabilities and neurological diseases 2006, 175-194. Elsevier, Amsterdam. R.D. Wells, T. Ashizawa (Eds.).
71. Park C.S., Tang S.J. Regulation of microRNA expression by induction of bidirectional synaptic plasticity. Journal of molecular neuroscience 2009, 38:50-56.
72. Penzes P., Cahill M.E., Jones K.A., VanLeeuwen J.E., Woolfrey K.M. Dendritic spine pathology in neuropsychiatric disorders. Nature Neuroscience 2011, 14:285-293.
73. Pinter J.D., Eliez S., Schmitt J.E., Capone G.T., Reiss A.L. Neuroanatomy of Down's syndrome: A high-resolution MRI study. The American Journal of Psychiatry 2001, 158:1659-1665.
74. Purpura R.P. Dendritic spine dysgenesis and mental retardation. Science 1974, 186:1126-1128.
75. Ramakers G.J. Rho proteins, mental retardation and the cellular basis of cognition. Trends in Neurosciences 2002, 25:191-199.
76. Ramakrishna N., Meeker C., Li S., Jenkins E.C., Currie J.R., Flory M., et al. Polymerase chain reaction method to identify Down syndrome model segmentally trisomic mice. Analytical Biochemistry 2005, 340:213-219.
77. Reeve S.P., Bassetto L., Genova G.K., Kleyner Y., Leyssen M., Jackson F.R., et al. The Drosophila fragile x mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Current Biology 2005, 15:1156-1163.
78. Ropers H.H. X-linked mental retardation: Many genes for a complex disorder. Current Opinion in Genetics and Development 2006, 16:260-269.
79. Saran N.G., Pletcher M.T., Natale J.E., Cheng Y., Reeves R.H. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Human Molecular Genetics 2003, 12:2013-2019.
80. Schalock R.L., Luckasson R.A., Shogren K.A., Borthwick-Duffy S., Bradley V., Buntinx W.H., et al. The renaming of mental retardation: Understanding the change to the term intellectual disability. Intellectual and Developmental Disabilities 2007, 45:116-124.
81. Schenck A., Bardoni B., Langmann C., Harden N., Mandel J.L., Giangrande A. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 2003, 38:887-898.
82. Schuett J., Falley K., Richter D., Kreienkamp H.J., Kindler S. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. Journal of Biological Chemistry 2009, 284:25479-25487.
83. Schule B., Armstrong D.D., Vogel H., Oviedo A., Francke U. Severe congenital encephalopathy caused by MECP2 null mutations in males: Central hypoxia and reduced neuronal dendritic structure. Clinical Genetics 2008, 74:116-126.
84. Schuman E.M., Dynes J.L., Steward O. Synaptic regulation of translation of dendritic mRNAs. Journal of Neuroscience 2006, 26:7143-7146.
85. Shepherd G.M., Katz D.M. Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: Focus on Mecp2 and Met. Current Opinion in Neurobiology 2011, 21:827-833.
86. Siarey R.J., Stoll J., Rapoport S.I., Galdzicki Z. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Neuropharmacology 1997, 36:1549-1554.
87. Siarey R.J., Carlson E.J., Epstein C.J., Balbo A., Rapoport S.I., Galdzicki Z. Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology 1999, 38:1917-1920.
88. Siarey R.J., Villar A.J., Epstein C.J., Galdzicki Z. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Neuropharmacology 2005, 49:122-128.
89. Smrt R.D., Eaves-Egenes J., Barkho B.Z., Santistevan N.J., Zhao C., Aimone J.B., et al. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiology of Disease 2007, 27:77-89.
90. Steward O. mRNA at synapses, synaptic plasticity, and memory consolidation. Neuron 2002, 36:338-340.
91. Su T., Fan H.X., Jiang T., Sun W.W., Den W.Y., Gao M.M., et al. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome. Psychopharmacology 2010, 215:291-300.
92. Sultan M., Piccini I., Balzereit D., Herwig R., Saran N.G., Lehrach H., et al. Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biology 2007, 8:R91.
93. van Bokhoven H., Kramer J.M. Disruption of the epigenetic code: An emerging mechanism in mental retardation. Neurobiology of Disease 2010, 39:3-12.
94. Vanderklish P.W., Edelman G.M. Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1639-1644.
95. Vissers L.E., de Ligt J., Gilissen C., Janssen I., Steehouwer M., de Vries P., et al. A de novo paradigm for mental retardation. Nature Genetics 2010, 42:1109-1112.
96. von Bohlen Und Halbach O. Structure and function of dendritic spines within the hippocampus. Annals of Anatomy 2009, 191:518-531.
97. Waung M.W., Pfeiffer B.E., Nosyreva E.D., Ronesi J.A., Huber K.M. Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate. Neuron 2008, 59:84-97.
98. Willemsen R., Oostra B.A., Bassell G.J., Dictenberg J. The fragile X syndrome: From molecular genetics to neurobiology. Mental Retardation and Developmental Disabilities Research Reviews 2004, 10:60-67.
99. Willemsen R., Levenga J., Oostra B. CGG repeat in the FMR1 gene: Size matters. Clinical Genetics 2011, 80:214-225.
100. Wisniewski K.E. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. American Journal of Medical Genetics. Supplement 1990, 7:274-281.
101. Yang G., Pan F., Gan W.B. Stably maintained dendritic spines are associated with lifelong memories. Nature 2009, 462:920-924.
102. Zalfa F., Giorgi M., Primerano B., Moro A., Di Penta A., Reis S., et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003, 112:317-327.
103. Zhang Y., Venkitaramani D.V., Gladding C.M., Kurup P., Molnar E., Collingridge G.L., et al. The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. Journal of Neuroscience 2008, 28:10561-10566.